Giving young children vitamin D supplements may ward off the development of type 1 diabetes in later life, research suggests. Children who took supplements were around 30 percent less likely to develop the condition than those who did not.

The study, by St Mary's Hospital for Women and Children, Manchester, appears in Archives of Disease in Childhood. Type 1diabetes is an autoimmune disorder, in which insulin producing beta cells in the pancreas are destroyed by the body's own immune system, starting in early infancy

Glucosamine sulfate, a supplement commonly used as a treatment for osteoarthritis does not seem to lessen pain in hip arthritis, according to a new study in Netherlands.

Rianna Rozendaal, M.Sc., the study's lead researcher at the Erasmus Medical Center in Rotterdam said that the results revealed that glucosamine sulfate does not appear to treat hip arthritis and that the difference between glucosamine and placebo group in treating mild to moderate hip arthritis were small

Heftier paychecks and all-expense-paid travels aren't the only advantages your boss has over you. A recent study published in the Australian Medical Journal revealed that managers are less likely to contract cancer than their rank and file counterparts are.

Deborah Schofield of Northern Rivers University Department of Rural Health was the lead researcher of the study. She noted that managers and administrators were significantly less likely to suffer neoplasms, or cancerous tumors, than all other level of workers

Research unveiled that a drug therapy using Rituxan (Rituximab) lessens the number of lesions that form along the nerve fibers of the brain of patients with multiple sclerosis.

Rituxan, used to treat rheumatoid arthritis and non-Hodgkin's lymphoma, provides an important effect in treating multiple sclerosis based on clinical trial

Americans are spending more on treating back and neck pain than almost any other medical condition, a new research suggests. Total spending on spine treatments in the United States totalled nearly $86 billion in 2005, a rise of 65 percent from 1997.

That is in line with annual expenditures for major conditions, including cancer, arthritis, and diabetes